Damora Therapeutics

Yahoo Finance • 10 days ago

Galecto GAAP EPS of -$3.98 misses by $3.02

* Galecto press release [https://seekingalpha.com/pr/20445542-damora-therapeutics-reports-full-year-2025-financial-results-and-recent-corporate-highlights] (DMRA [https://seekingalpha.com/symbol/DMRA]): FY GAAP EPS of -$3.98 misses by $3... Full story

Yahoo Finance • 10 days ago

Damora Therapeutics Reports Full-Year 2025 Financial Results and Recent Corporate Highlights

-- DMR-001 on track for IND or CTA submission in mid-2026, with two clinical proof-of-concept datasets expected beginning mid-2027 -- -- Strong financial position with approximately $535 million in cash and cash equivalents as of February... Full story